# Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria

> **NCT01115439** · — · COMPLETED · sponsor: **University of Oxford** · enrollment: 100 (actual)

## Conditions studied

- Falciparum Malaria

## Interventions

- **DRUG:** artesunate plus sulfadoxine-pyrimethamine (AS+SP)

## Key facts

- **NCT ID:** NCT01115439
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-07-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115439, "Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01115439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*